{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:26:30Z","timestamp":1760189190302,"version":"3.38.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.beha.2011.02.004","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T12:33:11Z","timestamp":1304944391000},"page":"121-134","source":"Crossref","is-referenced-by-count":10,"title":["Host genetics in follicular lymphoma"],"prefix":"10.1016","volume":"24","author":[{"given":"James R.","family":"Cerhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"SEER Cancer Statistics Review, 1975\u20132007","author":"Altekruse","key":"10.1016\/j.beha.2011.02.004_bib1"},{"key":"10.1016\/j.beha.2011.02.004_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.blre.2004.09.001","article-title":"Follicular lymphoma: time for a re-think?","volume":"19","author":"Gandhi","year":"2005","journal-title":"Blood Rev"},{"key":"10.1016\/j.beha.2011.02.004_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bcmd.2003.10.005","article-title":"Familial (inherited) leukemia, lymphoma, and myeloma: an overview","volume":"32","author":"Segel","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.beha.2011.02.004_bib4","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2009.26.1693","article-title":"Prognostic factors in follicular lymphoma","volume":"28","author":"Relander","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.004_bib5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","article-title":"Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands","volume":"86","author":"Goldgar","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2011.02.004_bib6","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(01)06721-6","article-title":"Analysis of hereditary component of cancer by use of a familial index by site","volume":"358","author":"Lindelof","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2011.02.004_bib7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2005-01-0140","article-title":"Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database","volume":"106","author":"Altieri","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.2009.07721.x","article-title":"Highly increased familial risks for specific lymphoma subtypes","volume":"146","author":"Goldin","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2011.02.004_bib9","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.20189","article-title":"Familial aggregation of Hodgkin lymphoma and related tumors","volume":"100","author":"Goldin","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2011.02.004_bib10","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2004-01-0341","article-title":"Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database","volume":"104","author":"Goldin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib11","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/ijc.21745","article-title":"Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study","volume":"118","author":"Landgren","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2011.02.004_bib12","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2008-06-162768","article-title":"Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia patients: a population-based study in Sweden","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib13","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2006-06-031948","article-title":"Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10,211 cases and 11,905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0145-2126(91)90005-E","article-title":"Familial cancers associated with subtypes of leukemia and non-Hodgkin\u2019s lymphoma","volume":"15","author":"Pottern","year":"1991","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2011.02.004_bib15","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jnci\/dji293","article-title":"Family history of hematopoietic malignancy and risk of lymphoma","volume":"97","author":"Chang","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2011.02.004_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2011.02.004_bib17","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/sj.leu.2402538","article-title":"Genetic susceptibility to chronic lymphocytic leukemia","volume":"16","author":"Houlston","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.02.004_bib18","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2007-05-091561","article-title":"A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia","volume":"110","author":"Sellick","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jmg.2004.027433","article-title":"A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4","volume":"42","author":"Goldin","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/507687","article-title":"Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families","volume":"79","author":"McMaster","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3324\/haematol.2009.006296","article-title":"The molecular basis of familial chronic lymphocytic leukemia","volume":"94","author":"Crowther-Swanepoel","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2011.02.004_bib22","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1126\/science.278.5343.1580","article-title":"Variations on a theme: cataloging human DNA sequence variation","volume":"278","author":"Collins","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.beha.2011.02.004_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The international HapMap Project","volume":"426","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.beha.2011.02.004_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrg2554","article-title":"Human genetic variation and its contribution to complex traits","volume":"10","author":"Frazer","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc B"},{"key":"10.1016\/j.beha.2011.02.004_bib26","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3324\/haematol.11011","article-title":"Genetic susceptibility to lymphoma","volume":"92","author":"Skibola","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2011.02.004_bib27","article-title":"A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis","author":"Nieters","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2011.02.004_bib28","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1182\/blood-2007-09-112144","article-title":"A functional TNFRSF5 gene variant is associated with risk of lymphoma","volume":"111","author":"Skibola","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib29","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1158\/0008-5472.CAN-08-4915","article-title":"Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma","volume":"69","author":"Novak","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2011.02.004_bib30","doi-asserted-by":"crossref","first-page":"e5360","DOI":"10.1371\/journal.pone.0005360","article-title":"Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk","volume":"4","author":"Wang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.beha.2011.02.004_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.coph.2004.02.009","article-title":"The role of the BAFF\/APRIL system in B cell homeostasis and lymphoid cancers","volume":"4","author":"Mackay","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.beha.2011.02.004_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2011.02.004_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/aje\/kwp383","article-title":"Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium","volume":"171","author":"Skibola","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.beha.2011.02.004_bib34","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1158\/1055-9965.EPI-08-0536","article-title":"Genetic variation in tumor necrosis factor and the nuclear factor-{kappa}B canonical pathway and risk of non-Hodgkin\u2019s Lymphoma","volume":"17","author":"Cerhan","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/carcin\/bgn262","article-title":"A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma","volume":"30","author":"Purdue","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.beha.2011.02.004_bib36","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1182\/blood-2007-05-088682","article-title":"Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma","volume":"110","author":"Cerhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1158\/1055-9965.EPI-08-1037","article-title":"Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development","volume":"18","author":"Morton","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/blood-2009-01-198697","article-title":"Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies","volume":"114","author":"Lan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib39","doi-asserted-by":"crossref","first-page":"e2816","DOI":"10.1371\/journal.pone.0002816","article-title":"Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma","volume":"3","author":"Skibola","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.beha.2011.02.004_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng.419","article-title":"Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma","volume":"41","author":"Skibola","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ng.626","article-title":"Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32","volume":"42","author":"Conde","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.610","article-title":"Estimation of effect size distribution from genome-wide association studies and implications for future discoveries","volume":"42","author":"Park","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib43","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1200\/JCO.2007.14.6571","article-title":"Survival patterns among lymphoma patients with a family history of lymphoma","volume":"26","author":"Anderson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.004_bib44","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00432-009-0618-0","article-title":"Survival in non-Hodgkin\u2019s lymphoma by histology and family history","volume":"135","author":"Ji","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.004_bib45","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1200\/JCO.2005.26.856","article-title":"Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors","volume":"23","author":"de Jong","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.004_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/gcc.1103","article-title":"Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)","volume":"30","author":"Horsman","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2011.02.004_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-3083.2003.01264.x","article-title":"Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells","volume":"57","author":"Eray","year":"2003","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.beha.2011.02.004_bib48","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1073\/pnas.0437875100","article-title":"Variation in gene expression patterns in follicular lymphoma and the response to rituximab","volume":"100","author":"Bohen","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2011.02.004_bib49","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2011.02.004_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2004-06-2298","article-title":"Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment","volume":"105","author":"Glas","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib51","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/0008-5472.CAN-05-3705","article-title":"Germ line polymorphism in metastatic progression","volume":"66","author":"Hunter","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2011.02.004_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/35101056","article-title":"Pharmacogenetics and cancer therapy","volume":"1","author":"Relling","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.beha.2011.02.004_bib53","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V91.10.3574","article-title":"Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin\u2019s lymphoma outcome","volume":"91","author":"Warzocha","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2141.1999.01704.x","article-title":"Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma","volume":"107","author":"Fitzgibbon","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2011.02.004_bib55","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/blood-2006-11-058040","article-title":"Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival","volume":"109","author":"Cerhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib56","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L\/R\/H phenotype","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib57","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib58","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1200\/JCO.2003.05.013","article-title":"Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma","volume":"21","author":"Weng","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.004_bib59","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/annonc\/mdi320","article-title":"Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)","volume":"16","author":"Ghielmini","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2011.02.004_bib60","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3816\/CLM.2007.n.004","article-title":"Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy","volume":"7","author":"Hatjiharissi","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.beha.2011.02.004_bib61","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1200\/JCO.2004.06.003","article-title":"Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype","volume":"22","author":"Weng","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.004_bib62","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3324\/haematol.12638","article-title":"Lack of prognostic value of FCGR3A-V158F polymorphism in non-Hodgkin\u2019s lymphoma","volume":"93","author":"Pennell","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2011.02.004_bib63","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3324\/haematol.11288","article-title":"Fc\u03b3RIIIA and Fc\u03b3RIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin\u2019s lymphoma patients treated with sequential CHOP and rituximab","volume":"92","author":"Carlotti","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2011.02.004_bib64","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/leu.2008.240","article-title":"Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma","volume":"23","author":"Wang","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.02.004_bib65","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/10428190601158647","article-title":"Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin\u2019s Lymphoma","volume":"48","author":"Hohaus","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2011.02.004_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.21580","article-title":"Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival","volume":"85","author":"Han","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2011.02.004_bib67","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib68","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/1055-9965.779.13.5","article-title":"Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiology","volume":"13","author":"Skibola","year":"2004","journal-title":"Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib69","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/blood-2004-02-0557","article-title":"Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma","volume":"104","author":"Skibola","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib70","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.2004.05358.x","article-title":"Association of NAT and GST polymorphisms with non-Hodgkin\u2019s lymphoma: a population-based case-control study","volume":"128","author":"Chiu","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2011.02.004_bib71","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1158\/1055-9965.EPI-05-0515","article-title":"Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes","volume":"14","author":"Lightfoot","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib72","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1055-9965.EPI-05-0343","article-title":"Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk","volume":"14","author":"Skibola","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib73","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1055-9965.EPI-04-0895","article-title":"Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma","volume":"14","author":"Skibola","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib74","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.2005.05505.x","article-title":"Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma","volume":"129","author":"Skibola","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2011.02.004_bib75","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjc.6602762","article-title":"Non-Hodgkin\u2019s lymphoma, obesity and energy homeostasis polymorphisms","volume":"93","author":"Willett","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2011.02.004_bib76","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jnci\/dji344","article-title":"A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma","volume":"97","author":"Zhang","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2011.02.004_bib77","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/1055-9965.EPI-06-0193","article-title":"Metabolic gene variants and risk of non-Hodgkin\u2019s lymphoma","volume":"15","author":"De Roos","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2006.06141.x","article-title":"Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma","volume":"134","author":"Forrest","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2011.02.004_bib79","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2005-01-026690","article-title":"Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes","volume":"108","author":"Hill","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib80","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2005-10-4160","article-title":"Cytokine polymorphisms in the Th1\/Th2 pathway and susceptibility to non-Hodgkin lymphoma","volume":"107","author":"Lan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib81","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/01.fpc.0000215071.59836.29","article-title":"Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma","volume":"16","author":"Morton","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.beha.2011.02.004_bib82","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2005-04-1567","article-title":"Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas","volume":"108","author":"Niclot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib83","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00439-006-0177-2","article-title":"Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut","volume":"119","author":"Shen","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib84","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/1055-9965.EPI-05-0583","article-title":"Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma","volume":"15","author":"Smedby","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib85","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2006.06030.x","article-title":"Association between non-Hodgkin lymphoma and haplotypes in the TNF region","volume":"133","author":"Spink","year":"2006","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.beha.2011.02.004_bib86","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1158\/0008-5472.CAN-06-0324","article-title":"Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-hodgkin lymphoma","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2011.02.004_bib87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00439-006-0212-3","article-title":"Cyclin D1 splice variant and risk for non-Hodgkin lymphoma","volume":"120","author":"Wang","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib88","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/carcin\/bgl013","article-title":"Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma","volume":"27","author":"Wang","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.beha.2011.02.004_bib89","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1080\/10428190701615926","article-title":"Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma","volume":"48","author":"Lech-Maranda","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2011.02.004_bib90","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00439-007-0431-2","article-title":"One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia","volume":"122","author":"Lee","year":"2007","journal-title":"Hum Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib91","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2006-07-034330","article-title":"Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study","volume":"109","author":"Lim","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib92","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/1055-9965.EPI-06-0639","article-title":"Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma","volume":"16","author":"Novik","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.beha.2011.02.004_bib93","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3324\/haematol.11053","article-title":"Vitamin D receptor gene polymorphisms and risk of non-Hodgkin\u2019s lymphoma","volume":"92","author":"Purdue","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2011.02.004_bib94","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/carcin\/bgl200","article-title":"Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study","volume":"28","author":"Purdue","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.beha.2011.02.004_bib95","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2009.07675.x","article-title":"Risk of non-Hodgkin lymphoma in association with germline variation in complement genes","volume":"145","author":"Cerhan","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2011.02.004_bib96","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1158\/0008-5472.CAN-08-4572","article-title":"Clock-cancer connection in non-Hodgkin\u2019s lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2","volume":"69","author":"Hoffman","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2011.02.004_bib97","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2350-10-117","article-title":"Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma","volume":"10","author":"Schuetz","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.beha.2011.02.004_bib98","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1182\/blood-2010-01-266775","article-title":"Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology","volume":"115","author":"Wang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.004_bib99","first-page":"1222","article-title":"Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin\u2019s lymphoma","volume":"91","author":"Lightfoot","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2011.02.004_bib100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.13533","article-title":"Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma","volume":"94","author":"Wrench","year":"2009","journal-title":"Haematologica"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:56:56Z","timestamp":1741179416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692611000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1521692611000119"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2011.02.004","relation":{},"ISSN":["1521-6926"],"issn-type":[{"type":"print","value":"1521-6926"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}